"Global legal epidemiology: developing a science around whether, when and how international law can address global challenges" with Steven Hoffmann

Past Event

Date
02 October 2018, 6:30pm - 8:00pm

Location
Lecture Theatre, Oxford Martin School
34 Broad Street (corner of Holywell and Catte Streets), Oxford, OX1 3BD

Gavel on top of world map
© Adobestock/niyazz

Introducing a pioneering approach to ‘global legal epidemiology’, Professor Steven Hoffman, Oxford Martin Visiting Fellow, will discuss legal mechanisms available for coordinating international responses to transnational problems, their prospects, and their challenges. Global legal epidemiology is the scientific study of international law as a factor in the cause, distribution, and promotion of outcomes around the world. It involves evaluating the effectiveness of international legal mechanisms on the basis of their quantifiable effects and drawing implications for the development of future treaties.

Prof Hoffman will draw on examples from public health, including tobacco control and antimicrobial resistance, identifying wider lessons for potential international treaties in other domains such as the environment, human rights and trade.

To register: https://bookwhen.com/uehiro

This event will be followed by a drinks reception all welcome


About the speaker

Steven J. Hoffman is an Oxford Martin Fellow on the Oxford Martin Programme on Collective Responsibility for Infectious Disease; the Director of the Global Strategy Lab, a Professor of Global Health, Law, and Political Science at York University, and the Scientific Director of the Canadian Institutes of Health Research’s Institute of Population & Public Health. He holds courtesy appointments as a Professor of Clinical Epidemiology & Biostatistics (Part-Time) at McMaster University and Adjunct Professor of Global Health & Population at Harvard University.

He is an international lawyer licensed in both Ontario and New York who specialises in global health law, global governance and institutional design. His research integrates analytical, empirical and big data approaches to craft global regulatory strategies that better address transnational health threats, social inequalities and human rights challenges. Past studies have focused on access to medicines, antimicrobial resistance, health misinformation, pandemics and tobacco control.